ARCHIVES

Includes April issue of Business & Regulatory Report (8 pages).

This article is from The Cancer Letter archive.

Vol. 29 No. 18 | May 2, 2003

Download PDF Visit The Full Archive

Related Articles

Conversation with The Cancer Letter: UT System Vice Chancellor Shine Describes Rationale for Granting Waiver to DePinho

October 26, 2012

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

December 18, 2009

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

November 16, 2001

DRCCA Board Approves CCOP, Limited Recompetition Of Cooperative Group Program, New Control Efforts

October 30, 1981

Director’s Advisory Committee to Make Advice “Kosher”

March 7, 1997

Tamoxifen Makes ER-Negative Breast Cancer Easier To Find

October 31, 2008